Provider: Excerpta Medica

Share this article:
Company Profile
Excerpta Medica Inc., an Elsevier business, is a global medical communications company headquartered in the US and The Netherlands. Since 1946, Excerpta Medica (www.excerptamedica.com) has been partnering with its clients in the pharmaceutical and biotech industries to ensure healthcare professionals will have the information they need to make informed decisions regarding treatment options for their patients. As part of Elsevier, the world's largest medical and scientific publisher,Excerpta Medica leverages Elsevier's many resources to build unique and powerful medical communications solutions.

Services and Offerings
The team of professionals at Excerpta Medica creates and delivers a full line of strategic solutions in the areas of:

Publication Planning:
Excerpta Medical develops and implements publication plans, produces abstracts and posters for scientific congresses, and performs gap and competitor analyses.

Medical Education:
We deliver a range of strategic, scientific and creative communication solutions including symposia, teleconferences, advisory board and investigator meetings, slide kits and e-media.

Custom and Medical Publishing:
We offer a variety of publication solutions ranging from peer-reviewed titles and industry-sponsored publications to customized communication solutions based on clien and target audience needs.

Interactive Solutions:
Our award-winning team at Excerpta Medica Interactive creates and implements innovative online medical communications solutions that successfully drive clients' educational strategies. We achieve our clients' goals by creating innovative, intuitive and interactive solutions for the world's leading healthcare brands.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"